| 摘要: |
| 在新的药品注册监管法规体系下,研制现场核查是促进药品研发过程,实现数据真实可追溯,推动药品研发行业规范和高质量发展的重要监管措施。本文结合生物制品特点和近年来核查工作实践,对生物制品药学研制现场核查关注的重点内容和发现的常见问题进行总结和分析,以期为生物制品研发和注册提供借鉴,为生物制品研制现场核查工作提供参考。 |
| 关键词: 生物制品 药学研制 核查要点 处方设计 |
| DOI:10.13506/j.cnki.jpr.2025.12.008 |
| 基金项目: |
|
出版日期:2025-12-25
|
|
| The key points and common problem analysis for pharmaceuticalresearch and development of biological products |
| ZHANG Pin1,SONG Kai2 |
| (1.Center for Food and Drug Inspection of NMPA, Beijing 100076, China; 2.Center for Food and Drug Evaluation and Inspection of Shandong Province, Jinan 250014, China) |
| Abstract: |
| Under the new regulatory framework for drug registration, the verification of pharmaceutical research and development of biological products as a crucial supervisory tool to promote the authenticity and traceability of data in the drug development process, as well as to advance the standardization and high-quality development of the pharmaceutical R&D. Based on the characteristics of biological products and practical inspection experiences in recent years. This article summarizes and analyzes the key focus points and common issues identified during the site inspections of biological products. The aim is to provide insights for the research and development, and registration of biological products, as well as to offer references for the related inspections. |
| Key words: Biological Products Pharmaceutical research and development Key points of inspection Common issues |